Jeena Sikho Lifecare submits FY26 sustainability report to exchanges

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Jeena Sikho Lifecare Limited filed its FY26 BRSR with NSE and BSE on September 4, 2026
  • The report adheres to SEBI Listing Obligations and Disclosure Requirements Regulation 34(2)(f)
  • The BRSR is included in the company's Integrated Annual Report for FY26
  • Manish Grover, Managing Director, signed the compliance submission
powered bylight_fuzz_icon
50076668

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY26 to the National Stock Exchange of India Limited and BSE Limited on September 4, 2026.

The filing complies with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The BRSR forms an integral part of the company's Integrated Annual Report for the financial year.

Regulatory Compliance Details

The submission was signed by Manish Grover, Managing Director of Jeena Sikho Lifecare . The document confirms that the Integrated Annual Report, including the BRSR, is available on the company's website.

Key Filing Information

Detail Information
Report Type Business Responsibility and Sustainability Report
Financial Year FY26
Regulation SEBI LODR Regulation 34(2)(f)
Submission Date September 4, 2026
Signatory Manish Grover (Managing Director)

The company operates over 120 Ayurveda clinics and hospitals, focusing on holistic healthcare solutions.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.96%+2.87%-11.36%-14.82%-31.92%0.0%

How might Jeena Sikho Lifecare's FY26 sustainability metrics influence investor sentiment in the broader Ayurveda and holistic healthcare sector?

What specific ESG initiatives outlined in the BRSR could drive operational efficiency or cost savings for the company's 120+ clinic network?

Could this compliance filing signal an upcoming expansion strategy or new product launches aligned with Jeena Sikho's sustainability goals?

Jeena Sikho Lifecare launches Narie Xpert and Porush Xpert Ayurvedic products

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Jeena Sikho Lifecare launched six new Ayurvedic products on September 2, 2026
  • New range includes Narie Xpert and Porush Xpert in granule, syrup, and tablet forms
  • All products are targeted exclusively at the domestic Indian market
  • Disclosure made under SEBI LODR Regulation 30 and recent circulars
powered bylight_fuzz_icon
49903836

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare launched six new Ayurvedic healthcare products on September 2, 2026. The company introduced the Narie Xpert and Porush Xpert ranges to expand its domestic wellness portfolio.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Product Portfolio Expansion

The new offerings target specific health concerns within the Ayurvedic segment. Each product line is available in three formats: granules, syrup, and tablets.

Product Name Format Size
Narie Xpert Granules 80g
Narie Xpert Syrup 500 ml
Narie Xpert Tablet 52 Tab
Porush Xpert Granules 80g
Porush Xpert Syrup 500 ml
Porush Xpert Tablet 52 Tab

Market Focus

All six products are designated for the domestic market only. The filing explicitly states that international launch details are not applicable at this stage.

The company operates over 120 Ayurveda clinics and hospitals. It positioned these launches as part of its broader strategy to provide drug-free healthcare solutions.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.96%+2.87%-11.36%-14.82%-31.92%0.0%

How might the exclusive domestic focus of the Narie Xpert and Porush Xpert ranges impact Jeena Sikho Lifecare's revenue diversification strategy in the near term?

What is the projected timeline for potential international expansion, and what regulatory hurdles must be cleared for these Ayurvedic products to enter global markets?

How do analysts expect the integration of these new product lines into the company's 120+ clinic network to influence patient retention and average transaction values?

More News on Jeena Sikho Lifecare

1 Year Returns:-31.92%